Scotland · NHS Scotland MSAN
Propafenone (Arythmol®) 150mg tablets
MSAN(2026)19 · Level 2 · issued 24 Jun 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Propafenone (Arythmol®) 150mg tablets are out of stock until late July 2026. | Out of stock | late July 2026 |
| 2. Propafenone (Arythmol®) 300mg tablets remain available and can support a limited increase in | Available — partial uplift only | — |
| 3. Flecainide 50mg and 100mg tablets remain available and can support increased demand. | Available | — |
| 4. Alternative medicines for ventricular and supraventricular arrhythmias remain available. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and organisations | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2026:19
- Recorded
- 06 Aug 2026 21:25 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 06 Aug 2026 21:25 UTC
- Content hash
868e5fa5929801f57eb8b3d8bf6e3581a8291da12a24561c7e1e46115c84ad60sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2026-19.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.